Veopoz
Pozelimab · Regeneron Pharmaceuticals, Inc.
PRESCRIPTION ONLY (USA)Veopoz ingredients
| Active ingredient | Strength |
|---|---|
| Pozelimab | 200 mg/mL |
What Veopoz is used for
Veopoz is a specialist medicine (complement inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Veopoz
- Generic name
- Pozelimab
- Made by
- Regeneron Pharmaceuticals, Inc.
- Forms
- Injection, Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Complement Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761339
- On the US market since
- 2023
Official information
- Veopoz prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Pozelimab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Veopoz?
Veopoz (Pozelimab) is a specialist medicine made by Regeneron Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Veopoz?
Veopoz contains Pozelimab (200 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA